Cargando…
Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441544/ https://www.ncbi.nlm.nih.gov/pubmed/33334809 http://dx.doi.org/10.2337/dc20-2080 |
| _version_ | 1783752889804521472 |
|---|---|
| author | Zaccardi, Francesco Kloecker, David E. Buse, John B. Mathieu, Chantal Khunti, Kamlesh Davies, Melanie J. |
| author_facet | Zaccardi, Francesco Kloecker, David E. Buse, John B. Mathieu, Chantal Khunti, Kamlesh Davies, Melanie J. |
| author_sort | Zaccardi, Francesco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8441544 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84415442021-09-29 Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes Zaccardi, Francesco Kloecker, David E. Buse, John B. Mathieu, Chantal Khunti, Kamlesh Davies, Melanie J. Diabetes Care e-Letters: Observations American Diabetes Association 2021-02 2020-12-17 /pmc/articles/PMC8441544/ /pubmed/33334809 http://dx.doi.org/10.2337/dc20-2080 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Observations Zaccardi, Francesco Kloecker, David E. Buse, John B. Mathieu, Chantal Khunti, Kamlesh Davies, Melanie J. Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| title | Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| title_full | Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| title_fullStr | Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| title_full_unstemmed | Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| title_short | Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes |
| title_sort | use of metformin and cardiovascular effects of new classes of glucose-lowering agents: a meta-analysis of cardiovascular outcome trials in type 2 diabetes |
| topic | e-Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441544/ https://www.ncbi.nlm.nih.gov/pubmed/33334809 http://dx.doi.org/10.2337/dc20-2080 |
| work_keys_str_mv | AT zaccardifrancesco useofmetforminandcardiovasculareffectsofnewclassesofglucoseloweringagentsametaanalysisofcardiovascularoutcometrialsintype2diabetes AT kloeckerdavide useofmetforminandcardiovasculareffectsofnewclassesofglucoseloweringagentsametaanalysisofcardiovascularoutcometrialsintype2diabetes AT busejohnb useofmetforminandcardiovasculareffectsofnewclassesofglucoseloweringagentsametaanalysisofcardiovascularoutcometrialsintype2diabetes AT mathieuchantal useofmetforminandcardiovasculareffectsofnewclassesofglucoseloweringagentsametaanalysisofcardiovascularoutcometrialsintype2diabetes AT khuntikamlesh useofmetforminandcardiovasculareffectsofnewclassesofglucoseloweringagentsametaanalysisofcardiovascularoutcometrialsintype2diabetes AT daviesmelaniej useofmetforminandcardiovasculareffectsofnewclassesofglucoseloweringagentsametaanalysisofcardiovascularoutcometrialsintype2diabetes |